stelfonta
qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - psi - za liječenje neupotrebljiva, bez udaljenih metastaza (koji na pozornici) potkožnog pretilih stanica tumora, koji se nalazi na razini ili distalno na lakat ili skočnog zgloba kuka, i neupotrebljiva, sobe метастатические uzeli stanice kože рангоута tumora kod pasa.
mirataz
dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - mačke - za povećanje tjelesne težine mačke, doživljava loš apetit i gubitak težine, kao rezultat kronične bolesti.
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastična sredstva - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
rybrevant
janssen-cilag international n.v. - amivantamab - karcinom, ne-malih stanica pluća - antineoplastična sredstva - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
ipravent 20 mikrograma po potisku, stlačeni inhalat, otopina
cipla (eu) limited, hillbrow house, hillbrow road, esher, surrey, ujedinjeno kraljevstvo - ipratropii bromidum - stlačeni inhalat, otopina - 20 mikrograma/potisak - urbroj: jedna odmjerena doza (potiskom preko ventila) sadrži 20 mikrograma ipratropijevog bromida (u obliku hidrata)
nasoryl 0,5 mg/ml + 0,6 mg/ml sprej za nos, otopina
jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - ksilometazolinklorid ipratropijev bromid - sprej za nos, otopina - 0,5 mg/ml + 0,6 mg/ml - urbroj: 1 ml otopine sadrži 0,5 mg ksilometazolinklorida i 0,6 mg ipratropijevog bromida.
nasoryl m 0,5 mg/ml + 0,6 mg/ml sprej za nos, otopina
jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - ksilometazolinklorid ipratropijev bromid - sprej za nos, otopina - 0,5 mg/ml + 0,6 mg/ml - urbroj: 1 ml otopine sadrži 0,5 mg ksilometazolinklorida i 0,6 mg ipratropijevog bromida
otrivin duo 0,5 mg/ml + 0,6 mg/ml sprej za nos, otopina
glaxosmithkline dungarvan ltd., knockbrack, dungarvan, irska - xylometazolinum, ipratropii bromidum - sprej za nos, otopina - 0,5 mg/ml + 0,6 mg/ml - urbroj: 1 ml otopine sadrži 0,5 mg ksilometazolinklorida i 0,6 mg ipratropijevog bromida; 1 potisak spreja (oko 140 mikrolitara) sadrži 70 mikrograma ksilometazolinklorida i 84 mikrograma ipratropijevog bromida